Generic Semaglutide: Lower-Cost Semaglutide is Here!
BUY NOW
We Ship To The U.S. Only
When Will Ozempic Go Generic? What to Know About Ozempic Patent Expiration
- Posted On:
- 28 Jul, 2026
- 11 min read
-
Ozempic (Semaglutide): Once-weekly injectable for adults with type 2 diabetes or weight management.Starting From $329.99
10% Off On Your First Order
Click on the Copy Code button to copy your code.
No Expiry
Exclusive On Duty Free Meds Only
Ozempic is one of the several brand-name versions of semaglutide. It is used by over 7 million patients today to help them manage their weight and type 2 diabetes. This medication is used to help patients with lowering their blood sugar levels and A1C. It also lowers their risk of facing serious related problems like major cardiovascular events or kidney problems. GLP-1 drugs like Ozempic are growing in demand. This growing demand has also driven up the cost.
The growing price of Ozempic has led to increased interest among patients in purchasing cheaper versions. One of these cheaper options is generic semaglutide. This more affordable option was approved for sale in Canada on April 28, 2026, broadening the opportunities for U.S. patients. U.S. patients can now order this medication from Canada to their homes for $199 per month’s supply.
- Ozempic (Semaglutide): Once-weekly injectable for adults with type 2 diabetes or weight management.Starting From $329.99
10% Off On Your First Order
Click on the Copy Code button to copy your code.
No Expiry
Exclusive On Duty Free Meds Only
- Ozempic is a brand-name version of semaglutide used to manage type 2 diabetes and support weight loss
- Patent protections are keeping generic versions off the U.S. market until at least 2031
- This generic medication is now available for order from Canada to the U.S.
- Some countries like China and Brazil may also see generic options as early as 2026
- Generic versions can help reduce costs and improve access once patents expire
- Patients should avoid unapproved compounded versions
Understanding Ozempic and Its Patent Protection
Semaglutide is the active ingredient that makes up Ozempic. The two are essentially the same medication. However, Ozempic is a brand-name version. Both versions have approval. There may also be compounded semaglutide available. This is different from both regular semaglutide and Ozempic. Compounded semaglutide may also be used during periods of high demand but they are usually a combination of medications and lack approval. These formulations are not subject to the same safety and quality evaluations as approved medications. These compounded semaglutide medications may be sold illegally since semaglutide still has patent protection in the U.S. Novo Nordisk and the approved manufacturers for the generic semaglutide medications in Canada – like Apotex Inc. and Dr. Reddy’s Laboratories – do not make the compounded medication. Compounded medications may also work differently even though they are made with some of the same ingredients.
Novo Nordisk has received several different patents on various medications. The length of each of these patents can vary. Some may last up to 20 years. The exact length of the patent depends on the country the medication is being sold in – not necessarily the medication itself. No other manufacturers are allowed to make or distribute these medications while they are under patent protection.
Patent expirations also have an effect on the availability of generic versions of medications. Manufacturers are able to make their own cheaper generic variations of medications once patent protections expire. This allows them to profit from the medication and drives down the cost overall for the medication since there is more affordable competition. Studies on the price decrease of medications after patents have expired showed that some medications may cost as much as 20% to 30% less within the first year. This price will continue to decrease in the years that follow – often significantly. This means patients may see the price of Ozempic lowering significantly after the patent has expired. They may also have new and cheaper opportunities to buy generic versions from other manufacturers.
Ozempic Patent Expiration Timeline: When Will Ozempic Go Generic?
Ozempic is being used around the globe. However, the patents on this medication are not all set to expire at the same time in all of those countries. Exclusivity over the medication may last a while longer in countries like the U.S. This may mean higher prices and make the medication more difficult to afford for patients without insurance coverage. Other countries – like China and Brazil – may see more affordable prices sooner and quicker generic adoption.
The sale of generic semaglutide was just recently approved for sale in Canada on April 28, 2026. However, the expiration of the patent for semaglutide is currently set to expire in 2031 and the method patent is set to expire in 2033 in the U.S. Patent expiration for semaglutide in China is set a little sooner than the U.S.
Are There Generic Versions of Ozempic Available?
There is currently no approved generic version of Ozempic in the U.S. However, generic Ozempic was approved and has already begun distribution in Canada. This generic semaglutide can be ordered from Canada to the U.S. for $199 per month. Compounded semaglutide was also being sold to some patients as a replacement for the more expensive name-brand medication. The sales of cheaper generic semaglutide may reduce these sales and availability. This option is not as safe. Generic semaglutide is safe and approved – unlike compounded semaglutide – while still being a cheaper alternative to Ozempic.
Some other GLP-1 medications have already obtained approval for generic versions and may be another option for some patients. This includes Exenatide (Byetta) and Liraglutide (Victoza). The medications are also approved and safe to use when prescribed. Patients should never take any unapproved or counterfeit versions of any medication. Those medications have not been tested in the same way and can cause serious complications. There is also no guarantee that those medications are made of what their maker claims they are and doses may vary.
Alternatives to Ozempic
There are several other GLP-1 receptor agonist medications besides Ozempic that patients may be able to take instead. Some popular alternatives include Wegovy and Rybelsus. Wegovy does not necessarily need to be used for type 2 diabetes patients. It may also be used for strictly weight loss and related conditions. Rybelsus is another popular option because it comes in an oral form rather than an injection. It is also a semaglutide medication. Other popular alternatives include Mounjaro and Zepbound. These medications are also commonly used for weight management. Some patients may also choose to use other options such as Victoza, Saxenda, or Trulicity.
Not all of these alternatives are suitable for all patients. Each medication may work a little differently and cause different side effects. Patients should speak with their healthcare provider before taking any new medication to make sure the medication they are using will be safe and effective for them. These providers may also be able to suggest any additional alternatives the patient may use.
The Future of Generic Ozempic
The patents on Ozempic and the legal challenges surrounding it have had several different effects on the medication’s availability and as a generic semaglutide. Generic availability in the U.S. will not likely take place until at least 2031. This means the prices will remain high for a while longer and there will be more limited availability to patients. Other markets – like in Canada – have already got approval and begun releasing generic forms of the medication.
Other possible GLP-1 medication alternatives – like CagriSema – are currently being tested and several other countries are expected to be releasing their generic versions of the medication soon as other patents expire. This means some patients may be seeing some new and improved alternatives emerging in the near future.
Conclusion
Patients living in the U.S. will not be able to purchase an approved generic version of Ozempic until at least 2031. This makes the medication in higher demand and more challenging to afford. This is especially the case for patients purchasing their prescriptions without insurance coverage. These patients may still have the option to purchase generic semaglutide from Cananda to the U.S. for $199 per month. Patients should never purchase an unofficial semaglutide medication or semaglutide compound medication that does not have official approval. These medications do not undergo the same testing and regulatory review as approved drugs and may pose safety risks.
Patients may be able to discuss cheaper alternative medications with their healthcare providers to find another similar medication that would be safe for them. Patients can also find cheaper prices on their Ozempic prescriptions, and more affordable generic Ozempic, when they buy from a trusted Canadian prescription fulfillment service like Duty Free Meds. Explore our website today for lower prices on Ozempic and other weight loss medications.
Frequently Asked Questions
What sets compounded semaglutide apart from Ozempic?
These versions of Ozempic are custom-made and may include different ingredients in addition to semaglutide. These medications are not approved and do not undergo the same testing and regulatory review as approved drugs – making their safety less definite. They may include additives, undisclosed ingredients, and incorrect dosing. Most of the production for these compound variations has been banned.
Will generic Ozempic be more affordable?
Generic versions of any medications are usually more affordable. It can also help bring down the price of the name-brand medication variations since there will be increased competition. Generic semaglutide in Canada is already about $800 less per month than the list price of name-brand Ozempic in the U.S. Generic semaglutide can currently be purchased from Canada to the U.S. for $199 per month’s supply.
When will the Ozempic patent expire?
The exact expiration of the Ozempic patent depends on the country. The earliest expiration in the U.S. would be 2031. Other countries have already begun production and sale of generic semaglutide – like Canada – and several other countries are expected to soon follow.
Is generic Ozempic available outside of the US?
Yes. Generic semaglutide is available in Canada for $199 per month’s supply. Other countries are expected to soon follow as patent protections expire. However, there is still no FDA-approved generic version available in the U.S.
What are the risks of using an unapproved generic Ozempic version?
There are several risks associated with unapproved versions of Ozempic. These medications have unknown effectiveness and can cause certain dangerous reactions. They may also have impurities. There have also been several reports of patients using these unapproved versions and accidentally taking too high a dose of the medication – sometimes by as much as 5-20 times the recommended amount.
Sources
- https://www.ozempic.com/
- https://www.goodrx.com/classes/glp-1-agonists/glp-1-trends
- Amin, T. (20206, May 22). Canada and India now have generic Wegovy. Here’s why the U.S. doesn’t. Morningstar, Inc. https://www.morningstar.com/news/marketwatch/20260522133/canada-and-india-now-have-generic-wegovy-heres-why-the-us-doesnt
- Canada approves second generic semaglutide, the first G7 country to do so. (2026, May 1). Health Canada. https://www.canada.ca/en/health-canada/news/2026/05/canada-approves-second-generic-semaglutide-the-first-g7-country-to-do-so.html
- Ozempic® Pricing. (n.d.). Novo Pricing. https://www.novopricing.com/ozempic.html
Disclaimer: The information presented here is intended solely for educational purposes and should not be interpreted as medical advice, a diagnosis, or specific treatment recommendations. It does not imply endorsement of any particular medication or therapy. Health conditions and treatment responses can differ significantly between individuals; thus, this information is not a guarantee of safety, suitability, or effectiveness for anyone in particular. Always seek the guidance of a healthcare professional for personalized medical advice and consult them before making any health or treatment decisions.
